Cargando…

Reversal of Azole Resistance in Candida albicans by Human Neutrophil Peptide

With the spread of AIDS and the increase in immunocompromised patients, multi-drug-resistant fungal infections have become a serious concern among clinicians, predominantly in the developing world. Therefore, developing novel strategies and new drugs is essential to overcome drug resistance in funga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Mohammad Imran, Choudhry, Hani, Jahan, Sadaf, Rather, Irfan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953362/ https://www.ncbi.nlm.nih.gov/pubmed/36831048 http://dx.doi.org/10.3390/biomedicines11020513

Ejemplares similares

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

A Subtraction Genomics-Based Approach to Identify and Characterize New Drug Targets in Bordetella pertussis: Whooping Cough
por: Jamal, Alam, et al.
Publicado: (2022)

Candida albicans gains azole resistance by altering sphingolipid composition
por: Gao, Jiaxin, et al.
Publicado: (2018)

Azole Compounds as Inhibitors of Candida albicans: QSAR Modelling
por: Gheidari, Davood, et al.
Publicado: (2021)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013)

Author Correction: Candida albicans gains azole resistance by altering sphingolipid composition
por: Gao, Jiaxin, et al.
Publicado: (2019)

Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
por: Yuan, Rui, et al.
Publicado: (2021)

Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates
por: El-Ganiny, Amira M., et al.
Publicado: (2022)

Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole
por: Firinu, Davide, et al.
Publicado: (2011)

Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis
por: Zhang, Ming-rui, et al.
Publicado: (2020)

Synergistic Effects and Mechanisms of Combined Treatment With Harmine Hydrochloride and Azoles for Resistant Candida albicans
por: Li, Xiuyun, et al.
Publicado: (2019)

Corrigendum: Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
por: Yuan, Rui, et al.
Publicado: (2021)

618. Fluconazole-Resistant Candida albicans Vaginitis with Cross-Resistance to Azoles: A Case Report
por: Akdağ, Damla, et al.
Publicado: (2019)

Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro
por: Feng, Wenli, et al.
Publicado: (2021)

Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans
por: Li, Ling, et al.
Publicado: (2018)

Research of Mrr1, Cap1 and MDR1 in Candida albicans resistant to azole medications
por: Feng, Wenli, et al.
Publicado: (2018)

High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran
por: Zarrinfar, Hossein, et al.
Publicado: (2021)

The Adr1 transcription factor directs regulation of the ergosterol pathway and azole resistance in Candida albicans
por: Shrivastava, Manjari, et al.
Publicado: (2023)

Effect of Acetic Acid and Lactic Acid at Low pH in Growth and Azole Resistance of Candida albicans and Candida glabrata
por: Lourenço, Andreia, et al.
Publicado: (2019)

Azole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi
por: Mansfield, Bryce E., et al.
Publicado: (2010)

Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole
por: Kukurudz, Rebekah J, et al.
Publicado: (2022)

Candida albicans and Candida dubliniensis Show Different Trailing Effect Patterns When Exposed to Echinocandins and Azoles
por: Ayadi, Rania, et al.
Publicado: (2020)

Structural design of microbicidal cationic oligomers and their synergistic interaction with azoles against Candida albicans
por: Yuan, Yuan, et al.
Publicado: (2019)

Catechol thwarts virulent dimorphism in Candida albicans and potentiates the antifungal efficacy of azoles and polyenes
por: Jothi, Ravi, et al.
Publicado: (2021)

Principles of a New Protocol for Prediction of Azole Resistance in Candida albicans Infections on the Basis of ERG11 Polymorphisms
por: Caban, Monika, et al.
Publicado: (2016)

Persistence of Clonal Azole-Resistant Isolates of Candida albicans from a Patient with Chronic Mucocutaneous Candidiasis in Colombia
por: Ceballos-Garzon, Andrés, et al.
Publicado: (2020)

BTYNB, an inhibitor of RNA binding protein IGF2BP1 reduces proliferation and induces differentiation of leukemic cancer cells
por: Jamal, Alam, et al.
Publicado: (2023)

Comparative Lipidomics of Azole Sensitive and Resistant Clinical Isolates of Candida albicans Reveals Unexpected Diversity in Molecular Lipid Imprints
por: Singh, Ashutosh, et al.
Publicado: (2011)

Comparative Lipidomics in Clinical Isolates of Candida albicans Reveal Crosstalk between Mitochondria, Cell Wall Integrity and Azole Resistance
por: Singh, Ashutosh, et al.
Publicado: (2012)

In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans
por: Mahmoud, Dina Ezzat, et al.
Publicado: (2021)

Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt
por: Gerges, Marian A, et al.
Publicado: (2023)

Neutrophil Extracellular Traps in Candida albicans Infection
por: He, Yufei, et al.
Publicado: (2022)

Molecular mechanisms of azole resistance in Candida bloodstream isolates
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2019)

Azole potentiation in Candida species
por: Stenkiewicz-Witeska, Jan S., et al.
Publicado: (2023)

Quinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans
por: Xie, Fei, et al.
Publicado: (2016)

The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions
por: Warrilow, Andrew G., et al.
Publicado: (2019)

P048 Antifungal susceptibility and mechanism of azole resistance in Candida albicans clinical isolates from oropharyngeal candidiasis patients in Iran
por: Jahanshiri, Zahra
Publicado: (2022)

Author Correction: Catechol thwarts virulent dimorphism in Candida albicans and potentiates the antifungal efficacy of azoles and polyenes
por: Jothi, Ravi, et al.
Publicado: (2021)

Azole-resistant Candida blankii as a newly recognized cause of bloodstream infection
por: Al-Haqqan, A., et al.
Publicado: (2018)

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p257o3e6esmhlbvphteg0pusti